PDN Post Market, Multicenter, Prospective, Global Clinical Study
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- David Caraway, MD
Chief Medical Officer, Nevro Corp
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Neuroversion, Inc.
Anchorage, Alaska, United States
- Michigan Pain Specialists
Ann Arbor, Michigan, United States
- Henry Ford Health
West Bloomfield, Michigan, United States
- Ohio State University Wexner Medical Center
Columbus, Ohio, United States
- Clinical Investigations, Llc
Edmond, Oklahoma, United States
- Columbia Pain Management
Milwaukie, Oregon, United States
- Wellspan Interventional Pain Specialists
York, Pennsylvania, United States
- Virginia Interventional Pain & Spine Centers
Roanoke, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 5 Jul 2022
- Primary completion
- 31 Oct 2027
- Completion
- 31 Oct 2028
- Last update posted
- 26 Jun 2026
- Registered enrollment
- 497
- Registry id
- NCT05301816
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.